Third Harmonic Bio IPO Presentation Deck
September 2022, 24 slides
  1. Third Harmonic Bio
  2. Related Decks
  3. IPO Presentation Decks
advancing the next wave | Third Harmonic Bio
forward looking statements | Third Harmonic Bio
offering summary | Third Harmonic Bio
third harmonic clinical stage company with oral wild type kit inhibitor to treat mast cell mediated diseases | Third Harmonic Bio
mast cells are a fulcrum of allergy and inflammation a | Third Harmonic Bio
targeting kit has been shown to broadly inhibit mast cell activity inhibition of kit drives both mast cell all patients | Third Harmonic Bio
highly selective oral wild type kit inhibitor | Third Harmonic Bio
phase sad mad food effect in healthy volunteers | Third Harmonic Bio
summary | Third Harmonic Bio
mad safety summary | Third Harmonic Bio
hematology mean count | Third Harmonic Bio
hematology parameter comparison and in | Third Harmonic Bio
summary serum tryptase | Third Harmonic Bio
phase chronic inducible urticaria study design | Third Harmonic Bio
development second generation formulation to enter | Third Harmonic Bio
indication expansion severe asthma | Third Harmonic Bio
phase inducible allergic asthma trial concept design | Third Harmonic Bio
multiple upcoming clinical catalysts | Third Harmonic Bio
advancing the next wave | Third Harmonic Bio
out there it a horrible world | Third Harmonic Bio
| Third Harmonic Bio
nonclinical safety and toxicology profile | Third Harmonic Bio
sad safety and summary | Third Harmonic Bio
mad hematology panel lineage mean result | Third Harmonic Bio
See More
Third Harmonic Bio
IPO Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Inhibitor
Clinical development
Recent decks by Third Harmonic Bio
Investor Presentation
October 2022
See all presentations by Third Harmonic Bio (2 decks)
Related decks
BenevolentAI
Investor Presentation
October 2022
Erasca
Investor Presentation
January 2024
Alkermes
Investor Day
March 2021
BioAtla
IPO
December 2020
Hillstream BioPharma
Investor Presentation
July 2023
Nuvectis Pharma
Investor Presentation
July 2023
AbCellera
Results
November 2022
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Recent decks by Third Harmonic Bio
See all presentations (2 decks)
Investor Presentation
October 2022
BenevolentAI
Investor Presentation
October 2022
Erasca
Investor Presentation
January 2024
Alkermes
Investor Day
March 2021
BioAtla
IPO
December 2020
Hillstream BioPharma
Investor Presentation
July 2023
Nuvectis Pharma
Investor Presentation
July 2023
AbCellera
Results
November 2022
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights